Capital raised by Iyuda Therapeutics
1 Form D filing · first filed Mar 2026 · Owings Mills, MD
Chief Executive Officer
Signatory on Iyuda Therapeutics's Form D filings · $600K raised across 1
Robert Tennant is on file as Chief Executive Officer at Iyuda Therapeutics in Owings Mills, MD. Iyuda Therapeutics has 1 Form D filing on record, $600K raised in total. Robert Tennant appears as a signatory on the company's filings.
An off-the-shelf allogeneic cell therapy built from isolated leukocytes taken from an HLA-mismatched donor and depleted of CD8+ T cells, formulated so the cells do not engraft in the recipient. The approach is the subject of the company's lead patent family, filed in 2022 and published in the US, EP, WO and JP.
